Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase Ib/II study of BL-8040 in combination with Atezolizumab in patients with non-small cell cancer

Next Previous
Trial Profile

A phase Ib/II study of BL-8040 in combination with Atezolizumab in patients with non-small cell cancer

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 27 Nov 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atezolizumab (Primary) ; Motixafortide (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Sponsors Genentech

    • Most Recent Events

    • 21 Nov 2017 According to a BioLineRx media release, the company expects to initiate this trial by early 2018
    • 06 Jun 2017 New trial record
    • 01 Jun 2017 According to a BioLineRx media release, Genentech has filed regulatory submissions required to commence this trial and the company expects to initiate this trial in the second half of 2017 after receipt of regulatory approval.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top